Keytruda®

Zydus Lifesciences And Formycon Partner To Supply Keytruda® Biosimilar For Cancer Patients In US And Canada

Zydus Lifesciences And Formycon Partner To Supply Keytruda® Biosimilar For Cancer Patients In US And Canada

11 Dec 2025

2 min read

European Commission Approves Merck’s Keytruda® as First Anti-PD-1 Therapy for Resectable Locally Advanced Head and Neck Cancer

Precision Medicine

European Commission Approves Merck’s Keytruda® as First Anti-PD-1 Therapy for Resectable Locally Advanced Head and Neck Cancer

30 Oct 2025

2 min read

FDA Approves KEYTRUDA QLEX™ for Subcutaneous Use in Multiple Cancers

Precision Medicine

FDA Approves KEYTRUDA QLEX™ for Subcutaneous Use in Multiple Cancers

20 Sep 2025

2 min read

Read More

Voice Of HealthCare

vohnetwork.com